[Federal Register Volume 61, Number 167 (Tuesday, August 27, 1996)]
[Rules and Regulations]
[Page 43963]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-21528]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 105
[Docket No. 95N-310F]
Revocation of Certain Regulations Affecting Food
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule; confirmation of effective date.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is confirming the
effective date of July 3, 1996, of the final rule published in the
Federal Register of June 3, 1996 (61 FR 27771), that revoked
regulations on diabetic labeling and on sodium intake labeling. These
regulations were among those regulations identified by the agency for
revocation as a result of a page-by-page review of its regulations that
cover food and cosmetics. This regulatory review was in response to the
administration's ``Reinventing Government'' initiative that seeks to
streamline government and to ease the burden on regulated industry and
consumers.
DATES: Effective date confirmed: July 3, 1996. This revocation is
applicable for all products initially introduced or initially delivered
for introduction into interstate commerce on or after this date. Any
labels or labeling that require revision as a result of this revocation
shall comply no later than January 1, 1998.
FOR FURTHER INFORMATION CONTACT: Michelle A. Smith, Center for Food
Safety and Applied Nutrition (HFS-158), Food and Drug Administration,
200 C St. SW., Washington, DC 20204, 202-205-5099.
SUPPLEMENTARY INFORMATION: In the Federal Register of June 3, 1996 (61
FR 27771), FDA issued a final rule entitled ``Revocation of Certain
Regulations Affecting Food'' that, among other things, revoked
regulations on diabetic labeling in Sec. 105.67 (21 CFR 105.67) and on
sodium intake labeling in Sec. 105.69 (21 CFR 105.69).
FDA gave interested persons until July 3, 1996, to file written
objections to the revocation of these regulations and to request a
hearing on the specific provisions to which there were objections. No
objections or requests for hearing were received in response to the
final regulation.
List of Subjects in 21 CFR Part 105
Dietary foods, Food grades and standards, Food labeling, Infants
and children.
Therefore, under the Federal Food, Drug, and Cosmetic Act (secs.
201, 401, 403, 409, 411, 701, 721 of (21 U.S.C. 321, 341, 343, 348,
350, 371, 379e)) and under authority delegated to the Commissioner of
Food and Drugs (21 CFR 5.10), notice is hereby given that no objections
were received, and that the removal of Sec. 105.67 on diabetic labeling
and Sec. 105.69 on sodium intake labeling became effective on July 3,
1996. Any labels or labeling that require revision as a result of this
revocation shall comply no later than January 1, 1998.
Dated: August 15, 1996.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 96-21528 Filed 8-26-96; 8:45 am]
BILLING CODE 4160-01-F
